Skip to main content

asthma

By Laura Lovett | 12:59 pm | January 10, 2018
Preventative telemedicine could play a key role in helping school-aged children with asthma manage their condition.
By Jonah Comstock | 05:00 am | December 03, 2015
LifeMap Solutions, the San Jose-California startup behind the ResearchKit app Asthma Health, has launched its second app, COPD Navigator, for free in the app store.
By Jonah Comstock | 12:20 pm | November 03, 2015
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way.
By Jonah Comstock | 11:30 am | September 30, 2015
Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system.
By Jonah Comstock | 04:22 am | September 27, 2015
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company.
By Aditi Pai | 06:26 am | July 27, 2015
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
By Jonah Comstock | 10:45 am | July 22, 2015
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim.
By Jonah Comstock | 06:04 am | March 31, 2015
LifeMap Solutions, the San Jose, California-based company that recently collaborated with Apple on one of the flagship apps for Apple ResearchKit, has launched a new pilot with Mount Sinai Hospital in New York.
By Jonah Comstock | 04:54 am | January 13, 2015
Norwalk, Connecticut-based medication adherence platform company HealthPrize says it has succeeded in raising medication adherence an average of 54 percent across a series of pharma-sponsored pilot programs for various medical conditions, with sample sizes ranging from 250 to more than 7,000.
By Jonah Comstock | 11:38 am | November 11, 2014
Pleasanton, California-based Spirometrix, a company working on a breath analysis sensor for early detection and treatment of asthma and COPD, has raised $8.